Literature DB >> 11583140

Hypertension and chronotherapy: shifting the treatment paradigm.

L M Prisant1.   

Abstract

The treatment of diseases has been based on the concept of homeostasis and has not incorporated an understanding of biologic rhythms and their underlying mechanisms. Biologic rhythms are implicated in cardiovascular events. Failure to recognize the circadian decline in blood pressure may result in iatrogenic chronopathological events, including anterior ischemic optic neuropathy and cerebrovascular accidents. Chronotherapeutics is the purposeful alteration of drug level to match rhythms to optimize therapeutic outcomes and minimize size effects. For the treatment of hypertension, this idea has the potential for a therapeutic paradigm shift.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583140     DOI: 10.1016/s0895-7061(01)02173-2

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Drug delivery systems for treatment of systemic hypertension.

Authors:  L Michael Prisant; William J Elliott
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Nonarteritic anterior ischemic optic neuropathy.

Authors:  Niraj Desai; Milan R Patel; L Michael Prisant; Dilip A Thomas
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

Review 3.  Aortic dissection.

Authors:  L Michael Prisant; V R Prasad Nalamolu
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-06       Impact factor: 3.738

4.  A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery.

Authors:  Zaheeda Khan; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Valence M K Ndesendo; Viness Pillay
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.